Clinical Feature, Lifestyle Behavior and Non-Communicable Diseases Comorbidities Among Psoriasis Patients in Shanghai: Gender Disparity Analysis Based on a Cross-Sectional Study

References

• Griffiths CEM, van der Walt JM, Ashcroft DM., et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol. 2017;177(1):e4–e7. doi:10.1111/bjd.15610
   PubMed Web of Science ®Google Scholar
• Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205–212. doi:10.1111/jdv.13854
   PubMed Web of Science ®Google Scholar
• Kaufman BP, Alexis AF. Psoriasis in Skin of Color: insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups. Am J Clin Dermatol. 2018;19(3):405–423. doi:10.1007/s40257-017-0332-7
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–271. doi:10.1016/S0140-6736(07)61128-3
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: a Review. JAMA. 2020;323(19):1945–1960. doi:10.1001/jama.2020.4006
   PubMed Web of Science ®Google Scholar
• Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018;102(5s):18–20.
   PubMedGoogle Scholar
• Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377–390. doi:10.1016/j.jaad.2016.07.064
   PubMed Web of Science ®Google Scholar
• Amin M, Lee EB, Tsai TF, Wu JJ. Psoriasis and Co-morbidity. Acta dermato-venereologica. Acta dermato-venereologica. 2020;100(3):adv00033. doi:10.2340/00015555-3387
   PubMed Web of Science ®Google Scholar
• Lippi D, Bianucci R, Donell S. Gender medicine: its historical roots. Postgrad Med J. 2020;96(1138):480–486. doi:10.1136/postgradmedj-2019-137452
   PubMed Web of Science ®Google Scholar
• Grego S, Pasotti E, Moccetti T, Maggioni AP. “Sex and gender medicine”: il principio della medicina di genere [Sex and gender medicine: the foundation of gender medicine]. G Ital Cardiol (Rome). 2020;21(8):602–606. Italian. doi:10.1714/3405.33894
   PubMedGoogle Scholar
• Napolitano M, Mastroeni S, Fania L, et al. Sex- and gender-associated clinical and psychosocial characteristics of patients with psoriasis. Clin Exp Dermatol. 2020;45(6):705–711. doi:10.1111/ced.14218
   PubMed Web of Science ®Google Scholar
• Wei L, Chen S, Qiang Y, et al. Tobacco smoking was positively associated with metabolic syndrome among patients with psoriasis in Shanghai: a cross-sectional study. Tob Induc Dis. 2022;20:05. doi:10.18332/tid/144228
   PubMed Web of Science ®Google Scholar
• Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nature Rev Dis Primers. 2016;2:16082. doi:10.1038/nrdp.2016.82
   PubMed Web of Science ®Google Scholar
• Nowowiejska J, Baran A, Grabowska P, Lewoc M, Kaminski TW, Flisiak I. Assessment of life quality, stress and physical activity among patients with psoriasis. Dermatol Ther (Heidelb). 2022;12(2):395–406. doi:10.1007/s13555-021-00662-1
   PubMed Web of Science ®Google Scholar
• Purzycka-Bohdan D, Kisielnicka A, Zabłotna M, et al. Chronic plaque psoriasis in Poland: disease severity, prevalence of comorbidities, and quality of life. J Clin Med. 2022;11(5):1–16. doi:10.3390/jcm11051254
   Web of Science ®Google Scholar
• Chen L, Huang X, Xiao Y, Su J, Shen M, Chen X. Prevalence and risk factors of atopic dermatitis, psoriasis, acne, and urticaria in China. J Central South Univ Med Sci. 2020;45(4):449–455. doi:10.11817/j.issn.1672-7347.2020.190115
   Google Scholar
• Murer C, Sgier D, Mettler SK, et al. Gender differences in psoriasis: a Swiss online psoriasis survey. Arch Dermatol Res. 2021;313(2):89–94. doi:10.1007/s00403-020-02066-1
   PubMed Web of Science ®Google Scholar
• Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(2):243–258. doi:10.1111/bjd.19169
   PubMed Web of Science ®Google Scholar
• Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172(6):298–304. doi:10.1159/000249365
   PubMedGoogle Scholar
• Stutts LA, Blomquist KK. A longitudinal study of weight and shape concerns and disordered eating groups by gender and their relationship to self-control. Eat Weight Disord. 2021;26(1):227–237. doi:10.1007/s40519-020-00844-4
   PubMed Web of Science ®Google Scholar
• Gazel U, Ayan G, Solmaz D, Akar S, Aydin SZ. The impact of smoking on prevalence of psoriasis and psoriatic arthritis. Rheumatology. 2020;59(10):2695–2710. doi:10.1093/rheumatology/keaa179
   PubMed Web of Science ®Google Scholar
• Naldi L. Psoriasis and smoking: links and risks. Psoriasis. 2016;6:65–71.
   PubMedGoogle Scholar
• Armstrong AW, Armstrong EJ, Fuller EN, Sockolov ME, Voyles SV. Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol. 2011;165(6):1162–1168. doi:10.1111/j.1365-2133.2011.10526.x
   PubMed Web of Science ®Google Scholar
• Brenaut E, Horreau C, Pouplard C, et al. Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013;27(Suppl 3):30–35. doi:10.1111/jdv.12164
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Dominguez PL, Choi HK, Han J, Curhan G. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol. 2010;146(12):1364–1369. doi:10.1001/archdermatol.2010.204
   PubMedGoogle Scholar
• Zheng GY, Wei SC, Shi TL, Li YX. Association between alcohol, smoking and HLA-DQA1*0201 genotype in psoriasis. Acta Biochim Biophys Sin (Shanghai). 2004;36(9):597–602. doi:10.1093/abbs/36.9.597
   PubMed Web of Science ®Google Scholar
• Zheng Q, Sun XY, Miao X, et al. Association between physical activity and risk of prevalent psoriasis: a MOOSE-compliant meta-analysis. Medicine. 2018;97(27):e11394. doi:10.1097/MD.0000000000011394
   PubMed Web of Science ®Google Scholar
• Ferguson FJ, Lada G, Hunter HJA, et al. Diurnal and seasonal variation in psoriasis symptoms. J Eur Acad Dermatol Venereol. 2021;35(1):e45–e7. doi:10.1111/jdv.16791
   PubMed Web of Science ®Google Scholar
• Wu Q, Xu Z, Dan YL, et al. Seasonality and global public interest in psoriasis: an infodemiology study. Postgrad Med J. 2020;96(1133):139–143. doi:10.1136/postgradmedj-2019-136766
   PubMed Web of Science ®Google Scholar
• Kim E, Lee G, Fischer G. Use of narrowband ultraviolet B (NBUVB) in paediatric psoriasis: a systematic literature review and meta-analysis. Australas J Dermatol. 2021;62(2):124–129. doi:10.1111/ajd.13471
   PubMed Web of Science ®Google Scholar
• Stanescu AMA, Simionescu AA, Diaconu CC. Oral Vitamin D Therapy in Patients with Psoriasis. Nutrients. 2021;13(1):163. doi:10.3390/nu13010163
   PubMed Web of Science ®Google Scholar
• Rademaker M, Agnew K, Anagnostou N, et al. Psoriasis and infection. A clinical practice narrative. Australasian j Dermatol. 2019;60(2):91–98. doi:10.1111/ajd.12895
   PubMed Web of Science ®Google Scholar
• Huang YH, Kuo CF, Huang LH, Hsieh MY. Familial Aggregation of Psoriasis and Co-Aggregation of Autoimmune Diseases in Affected Families. J Clin Med. 2019;8(1):115. doi:10.3390/jcm8010115
   PubMed Web of Science ®Google Scholar
• Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN. Psoriasis and Genetics. Acta dermato-venereologica. Acta dermato-venereologica. 2020;100(3):adv00030. doi:10.2340/00015555-3384
   PubMed Web of Science ®Google Scholar
• Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36(1):21–28. doi:10.1016/j.clindermatol.2017.09.005
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68(4):654–662. doi:10.1016/j.jaad.2012.08.015
   PubMed Web of Science ®Google Scholar
• Salihbegovic EM, Kurtalic S, Omerkic E. Comorbidity in Men with Psoriasis. Med Arch. 2021;75(1):31–34. doi:10.5455/medarh.2021.75.31-34
   PubMedGoogle Scholar
• Su YS, Yu HS, Li WC, et al. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy. J Eur Acad Dermatol Venereol. 2013;27(7):876–883. doi:10.1111/j.1468-3083.2012.04599.x
   PubMed Web of Science ®Google Scholar
• Boehncke WH, Boehncke S, Tobin AM, Kirby B. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20(4):303–307. doi:10.1111/j.1600-0625.2011.01261.x
   PubMed Web of Science ®Google Scholar